Chemesis International Inc. Enters into Definitive Licensing Agreement to Manufacture Proprietary Patent Pending Dragonglass Flake and Bake™ THC Sublingual flake
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. Enters into Definitive Licensing Agreement to Manufacture
Proprietary Patent Pending Dragonglass Flake and Bake™ THC Sublingual flake
Puerto Rico-based Natural Ventures Enters into Definitive Licensing and Manufacturing Agreement with Project
1493 to Produce Dragonglass Flake and Bake™ for Puerto Rican Cannabis Market
January 17, 2018
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or
“Chemesis”), announces its subsidiary Nat ural Ventures has entered into a licensing agreement to
produce Dragonglass Flake and Bake™ (“Dragonglass”) for Project 1493 LLC., a subsidiary of GSRX
Industries, Inc. Dragonglass will be available exclusively at Green Spirit RX dispensaries throughout
Puerto Rico.
GSRX Industries Inc. ( OTCQB: GSRX ), one of Puerto Rico’s largest operators of medicinal cannabis
dispensaries (under the brand name Green Spirit RX), has five medicinal cannabis dispensaries on the
island, located in San Juan -Puerto Nu evo, San Juan -Hato Ray, Carolina, Dorado and Fajardo. These
dispensaries are located in prime areas with large populations that are in close proximity to tourist
centers and hotels. In anticipation of growing demand for cannabis related products including edibles
like Dragonglass, Green Spirit RX also has five additional locations in Puerto Rico expected to be opened
in 2019. The company also holds pre -qualified licenses in Puerto Rico for transportation and at -home
patient delivery. Furthermore, Project 14 93 and Green Spirit RX will lead all marketing efforts in Puerto
Rico to ensure cannabis consumers are educated on Dragonglass and its benefits.1
Dragonglass is made using a multi -patent pending technology that allows consumers to consume
cannabis in a variety of different methods, flavors and colors. The dried activated THC powder or flake is
all natural, and contains zero calories, sugar, fat, alcohols and is 100% vegan. The powder or flake is
produced via a proprietary water -based cannabinoid infusion me thod, which allows users to expect
onset within 7 -15 minutes. Dragonglass will come in a variety of flavors that include mint, cinnamon,
lemon-lime and even Cayenne for cooking. Dragonglass can be administered sublingually, ingested,
micro dosed, and added to foods or drinks.2
“We are tremendously pleased with the agreement to bring Dragonglass to cannabis consumers in
Puerto Rico,” said CEO of Chemesis, Edgar Montero. “Chemesis believes the patent -pending proprietary
technology could revolutionize the indu stry in Puerto Rico with its fast onset and versatile methods of
consumption. Natural Ventures will continue to increase its capabilities to serve the increasing demand
1 Green Spirit
2 Dragonglass
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
of Puerto Rico’s cannabis industry.”
Under the agreement, Project 1493 will provide for mulas, equipment, technology, and training to
manufacture Dragonglass at Natural Ventures’ Puerto Rico facility. Under the agreement, Chemesis
International and Project 1493 LLC. have a 50/50 net profit split.
The Company has also drawn down CDN $500,000 from the previously announced CDN $25 million
equity facility from Alumina Partners Ltd., a New York based private equity firm. The Company will issue
384,615 common shares at a price of CDN $1.30 and also issue 384,615 common share purchase
warrants at an exercise price of CDN $2.45 (“Warrants”). Each Warrant is exercisable for one common
share for a period of five years.
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently
operating within California, Puerto Rico, and Colombia.
Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution
and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective
production and distribution of its products. In addition, Chemesis leverages exclusive brands and
partnerships and uses the highest quality extraction methods to provide consumers with quality
cannabis products.
Chemesis will add shareholder value by exploring opportunities in emerging markets while consistently
delivering quality product to its consumers from seed to sale.
Investor Relations:
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
CaliforniaSap.instagram
Jay&SB.instagram
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of
applicable securities laws relating to statements regarding the Company's business, products and future of the
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Company’s business, its product offerings and plans for sales and marketing, includi ng finalizing an acquisition in
Colombia. Although the Company believes that the expectations reflected in the forward -looking information are
reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to
place undue reliance on forward -looking information. Such forward -looking statements are subject to risks and
uncertainties that may cause actual results, performance and developments to differ materially from those
contemplated by these statements depe nding on, among other things, the risks that the Company's products and
plan will vary from those stated in this news release and the Company may not be able to carry out its business
plans as expected. Except as required by law, the Company expressly disc laims any obligation and does not intend
to update any forward -looking statements or forward -looking information in this news release. Although the
Company believes that the expectations reflected in the forward -looking information are reasonable, there ca n be
no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales
reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release